Claims
- 1. An aminoalkoxyphenyl compound corresponding to the formula: ##STR77## as well as its pharmaceutically acceptable salts in which: B is selected from --S--, --SO-- and --SO.sub.2 --,
- R.sub.1 and R.sub.2, which are identical or different, are selected from the group consisting of hydrogen, methyl, ethyl, and halogen,
- A is selected from a straight or branched C.sub.2 -C.sub.5 alkylene radical, a 2-hydroxy propylene radical and a 2-(C.sub.1 -C.sub.4) alkoxy propylene radical,
- Am is selected from: ##STR78## in which: R.sub.3, R'.sub.3 and R".sub.3, which are identical or different, are selected form the group consisting of hydrogen, halogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy,
- R.sub.4 is selected from the group consisting of hydrogen and C.sub.1 -C.sub.8 alkyl,
- n plus m, which are identical or different, are selected from 0,1, and 2,
- R is in the .alpha.-position with respect to the methyne group attached to the group --B-- and is selected from hydrogen, C.sub.1 -C.sub.8 alkyl, C.sub.3 -C.sub.6 cycloalkyl, benzyl and phenyl optionally substituted by one or several substituents, which may be identical or different, selected from halogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy and nitro.
- 2. A method of treating angina pectoris, hypertension and arrhythmia comprising administering to a patient in need thereof an effective amount of at least one aminoalkoxyphenyl compound of the formula: ##STR79## as well as their pharmaceutically acceptable salts in which: B is selected from --S--, --SO-- and --SO.sub.2 --,
- R.sub.1 and R.sub.2, which are identical or different, are selected from the group consisting of hydrogen, methyl, ethyl, and halogen,
- A is selected from a straight or branched C.sub.2 -C.sub.5 alkylene radical, a 2-hydroxy propylene radical and a 2-(C.sub.1 -C.sub.4) alkoxy propylene radical,
- Am is selected from: ##STR80## in which: R.sub.3, R'.sub.3 and R".sub.3 which are identical or different, are selected form the group consisting of hydrogen, halogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy,
- R.sub.4 is selected from the group consisting of hydrogen and C.sub.1 -C.sub.8 alkyl,
- n plus m, which are identical or different, are selected from 0, 1, and 2,
- R is in the .alpha.-position with respect to the methyne group attached to the group --B-- and is selected from hydrogen, C1-C.sub.8 alkyl, C.sub.3 -C.sub.6 cycloalkyl, benzyl and phenyl optionally substituted by one or several substituents, which may be identical or different, selected from halogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy and nitro.
- 3. A method of reducing or controlling excessive intraocular pressure comprising administering to a patient in need thereof an effective amount of at least one aminoalkoxyphenyl compound of the formula: ##STR81## as well as their pharmaceutically acceptable salts in which: B is selected from --S--, --SO-- and --SO.sub.2 --,
- R.sub.1 and R.sub.2, which are identical or different, are selected from the group consisting of hydrogen, methyl, ethyl, and halogen,
- A is selected from a straight or branched C.sub.2 -C.sub.5 alkylene radical, a 2-hydroxy propylene radical and a 2--(C.sub.1 -C.sub.4) alkoxy propylene radical,
- Am is selected from: ##STR82## in which: R.sub.3, R'.sub.3 and R".sub.3 which are identical or different, are selected form the group consisting of hydrogen, halogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy,
- R.sub.4 is selected from the group consisting of hydrogen and C.sub.1 -C.sub.8 alkyl,
- n plus m, which are identical or different, are selected from 0, 1, and 2,
- R is in the .alpha.-position with respect to the methyne group attached to the group --B-- and is selected from hydrogen, C.sub.1 -C.sub.8 alkyl, C.sub.3 -C.sub.6 cycloalkyl, benzyl and phenyl optionally substituted by one or several substituents, which may be identical or different, selected from halogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy and nitro.
- 4. A method of treating glaucoma comprising administering to a patient in need thereof an effective amount of at least one aminoalkoxyphenyl compound of the formula: ##STR83## as well as their pharmaceutically acceptable salts in which: B is selected from --S--, --SO-- and --SO.sub.2 --,
- R.sub.1 and Rz, which are identical or different, are selected from the group consisting of hydrogen, methyl, ethyl, and halogen,
- A is selected from a straight or branched C.sub.2 -C.sub.5 alkylene radical, a 2-hydroxy propylene radical and a 2-(C.sub.1 -C.sub.4) alkoxy propylene radical,
- Am is selected from: ##STR84## in which: R.sub.3, R'.sub.3 and R".sub.3, which are identical or different, are selected form the group consisting of hydrogen, halogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy,
- R.sub.4 is selected from the group consisting of hydrogen and C.sub.1 -C.sub.8 alkyl,
- n, plus m, which are identical or different, are selected from 0, 1, and 2,
- R is in the .alpha.-position with respect to the methyne group attached to the group --B-- and is selected from hydrogen, C.sub.1 -C.sub.8 alkyl, C.sub.3 -C.sub.6 cycloalkyl, benzyl and phenyl optionally substituted by one or several substituents, which may be identical or different, selected from halogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy and nitro.
- 5. A method for the treatment of pathological syndromes of the cardiovascular system in a host in need of such treatment comprising the administration to said host of an effective amount of an aminoalkoxyphenyl derivative according to claim 1.
- 6. A method for the treatment of ocular diseases in a host in need of such treatment comprising the administration to said host of an effective amount of an aminoalkoxyphenyl derivative according to claim 1.
- 7. A cycloaminoalkoxyphenyl derivative according to claim 1 in which B represents a --SO.sub.2 --group.
- 8. A cycloaminoalkoxyphenyl derivative according to claim 1 in which R.sub.1 and R.sub.2 each denotes hydrogen.
- 9. A cycloaminoalkoxyphenyl derivative according to claim 1 in which R.sub.3, R'.sub.3 and R".sub.3 denote hydrogen or methoxy.
- 10. A cycloaminoalkoxyphenyl derivative according to claim 1 in which R represents the isopropyl or cyclopropyl group.
- 11. A cycloaminoalkoxyphenyl derivative according to claim 1 in which the pharmaceutically acceptable salt is the oxalate or the hydrochloride.
- 12. A cycloaminoalkoxyphenyl derivative according to claim 1 selected from: 1-{4-[3-(N-methyl N-6,7-dimethoxy 1,2,3,4-tetrahydronaphth-2-yl-amino) propoxy]benzenesulfonyl}2-isopropyl indolizine, 2-isopropyl-1-{4-[3-(N-methyl-N-5,6-dimethyoxyindan-1-yl-amino) propoxy]benzenesulfonyl}indolizine, and 2-isopropyl-l-{4-[3-(N-7-methoxy-1,2,3,4-tetrahydronaphth-2-yl-amino) propoxy]benzenesulphonyl}indolizine and their pharmaceutically acceptable salts.
- 13. An aminoalkoxyphenyl compound corresponding to the formula: ##STR85## as well as its pharmaceutically acceptable salts in which: B is selected from --S--, --SO--, and --SO.sub.2 --,
- R.sub.1 and R.sub.2, which are identical or different, are selected from the group consisting of hydrogen, methyl, ethyl, and halogen,
- A is selected from a straight or branched C.sub.2 --C.sub.5 alkylene radical, a 2-hydroxy propylene radical and a 2-(C.sub.1 -C.sub.4) alkoxy propylene radical,
- Am is selected from: ##STR86## in which: R.sub.3, R'.sub.3 and R".sub.3, which are identical or different, are selected from the group consisting of hydrogen, halogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy,
- R.sub.4 is selected from the group consisting of hydrogen and C.sub.1 -C.sub.8 alkyl,
- n plus m, which are identical or different, is 2,
- R is in the .alpha.-position with respect to the methyne group attached to the group --B-- and is selected from hydrogen, C.sub.1 -C.sub.8 alkyl, C.sub.3 -C.sub.6 cycloalkyl, benzyl and phenyl optionally substituted by one or several substituents, which may be identical or different, selected from halogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy and nitro.
Priority Claims (1)
Number |
Date |
Country |
Kind |
89 01555 |
Feb 1989 |
FRX |
|
Parent Case Info
This application is a continuation of U.S. application Ser. No. 07/476,518 filed Feb. 7, 1990 abandoned.
US Referenced Citations (11)
Foreign Referenced Citations (2)
Number |
Date |
Country |
0287696 |
Oct 1988 |
EPX |
2341578 |
Sep 1977 |
FRX |
Non-Patent Literature Citations (2)
Entry |
Alfred Burger, Chemical Structure and Biological Activity, pp. 64-80. |
Chemical Abstracts, vol. 109, p. 606, 6405, 1988. |
Continuations (1)
|
Number |
Date |
Country |
Parent |
476518 |
Feb 1990 |
|